About
RevBio, Inc. is a clinical-stage medical device company based in Lowell, Massachusetts. The company specializes in TETRANITE®, a patented synthetic bone adhesive biomaterial that is injectable, self-setting, load-bearing, and osteoconductive. Inspired by the marine sandcastle worm, TETRANITE is designed to bond bone to bone and bone to metal, even in wet surgical environments. This innovative technology aims to enhance bone repair by providing rapid mechanical stability and controlled biodegradability. RevBio's product platform targets various clinical markets, including dental, cranial, trauma, spinal, and veterinary applications. The company plans to launch its first product, a veterinary dental bone adhesive, by the end of 2024, followed by human-use products for dental and cranial applications by mid-2026. RevBio operates from the Massachusetts Medical Device Development Center (M2D2) and collaborates with leading research institutions to develop products based on TETRANITE technology. The company has secured multiple patents for its innovations and has received significant funding to support its development efforts.
Technologies
Keywords
Company Information
- Employees34
- Founded2014
- Annual Revenue$5500000
- Total Funding$37735087
Location
600 Suffolk St, Lowell, Massachusetts, United States, 01854
